The iPLEDGE program is a set of steps that all patients, prescribers, and pharmacists must follow prior to dispensing:

Rationale

The iPLEDGE program is a set of steps that all patients, prescribers, and pharmacists must follow prior to dispensing isotretinoin.

The iPLEDGE program is specifically designed to prevent fetal exposure to isotretinoin, a medication used to treat severe acne, due to its high risk of causing severe birth defects. This program mandates strict protocols to ensure that all participants are aware of the risks and follow necessary precautions.

A (dofetilide) YOUR ANSWER

Dofetilide is an antiarrhythmic medication used for the treatment of certain types of irregular heartbeats. It does not have a specific risk of causing birth defects that would necessitate a program like iPLEDGE. Therefore, it is not subject to the same stringent requirements as isotretinoin.

B (clozapine) YOUR ANSWER

Clozapine is an antipsychotic drug used primarily for treatment-resistant schizophrenia. While it has its own risk management protocols due to the risk of agranulocytosis, it is not associated with teratogenic effects like isotretinoin and does not fall under the iPLEDGE program.

C (thalidomide) YOUR ANSWER

Thalidomide, known for causing severe birth defects when taken during pregnancy, does have a Risk Evaluation and Mitigation Strategy (REMS) program to manage its distribution. However, it is not the iPLEDGE program, which is specifically tailored for isotretinoin.

D (isotretinoin) CORRECT

Isotretinoin is the only medication among the options listed that requires adherence to the iPLEDGE program due to its documented teratogenic effects. This program ensures that patients are educated about the risks and are using effective contraception to prevent unintended pregnancies while on the medication.

Conclusion

The iPLEDGE program is essential for managing the risks associated with isotretinoin use, particularly concerning its potential to cause serious birth defects. Unlike dofetilide, clozapine, and thalidomide, isotretinoin's specific risks necessitate a structured program to ensure patient safety and compliance. This highlights the importance of risk management strategies in pharmacotherapy, particularly for high-risk medications.

The iPLEDGE program is a set of steps that all patients, prescribers, and pharmacists must follow prior to dispensing:

The iPLEDGE program is a set of steps that all patients, prescribers, and pharmacists must follow prior to dispensing isotretinoin.

Related Questions

Related Quizzes

How familiar were you with this question?

Report an Issue

Rate this Practice Test